Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD

Graeme Hewitt, Valerie Borel, Sandra Segura-Bayona, Tohru Takaki, Phil Ruis, Roberto Bellelli, Laura Lehmann, Lucia Sommerova, Aleksandra Vancevska, Antonia Tomas-Loba, Kang Zhu, Christopher Cooper, Kasper Fugger, Harshil Patel, Robert Goldstone, Deborah Schneider-Luftman,, Ellie Herbert, Gordon Stamp, Rachel Brough, Stephen PettittChristopher Lord, Stephen West, Ivan Ahel, Dragana Ahel, Ross Chapman, Sebastian Deindl, Simon Boulton

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)


Chromatin is a barrier to efficient DNA repair, as it hinders access and processing of certain DNA lesions. ALC1/CHD1L is a nucleosome-remodeling enzyme that responds to DNA damage, but its precise function in DNA repair remains unknown. Here we report that loss of ALC1 confers sensitivity to PARP inhibitors, methyl-methanesulfonate, and uracil misincorporation, which reflects the need to remodel nucleosomes following base excision by DNA glycosylases but prior to handover to APEX1. Using CRISPR screens, we establish that ALC1 loss is synthetic lethal with homologous recombination deficiency (HRD), which we attri- bute to chromosome instability caused by unrepaired DNA gaps at replication forks. In the absence of ALC1 or APEX1, incomplete processing of BER intermediates results in post-replicative DNA gaps and a critical dependence on HR for repair. Hence, targeting ALC1 alone or as a PARP inhibitor sensitizer could be em- ployed to augment existing therapeutic strategies for HRD cancers.
Original languageEnglish
Article numbere11
Pages (from-to)767-783.e11
Number of pages17
JournalMolecular Cell
Issue number4
Early online date16 Dec 2020
Publication statusPublished - 18 Feb 2021
Externally publishedYes


Dive into the research topics of 'Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD'. Together they form a unique fingerprint.

Cite this